Efficacy and safety of oral minoxidil in comparison to topical form in male pattern hair loss
Authors:
- 20 August 2025
- journal article
- research article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-9
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Oral Minoxidil vs Topical Minoxidil for Male Androgenetic AlopeciaJAMA Dermatology, 2024
- Safety of Low-Dose Oral Minoxidil in Patients With Hypertension and Arrhythmia: A Multicenter Study of 264 PatientsActas Dermo-Sifiliograficas, 2023
- Androgenetic Alopecia: Therapy UpdateDrugs, 2023
- What’s New in Therapy for Male Androgenetic Alopecia?American Journal of Clinical Dermatology, 2022
- Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic AssessmentDermatology and Therapy, 2020
- Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: A randomized clinical trialJournal of the American Academy of Dermatology, 2020
- Androgenetic Alopecia: An Update of Treatment OptionsDrugs, 2016
- A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopeciaJournal of the American Academy of Dermatology, 2014
- A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in menJournal of the American Academy of Dermatology, 2007
- Severe HypertensionJAMA, 1975